News

CanniMed Therapeutics Inc. and CTT Pharmaceutical Holdings Inc.have entered into a definitive contractual relationship for the licensing of CTT’s Orally Dissolvable Thin Film (ODF)…
Read More...

Immune Pharmaceuticals Inc., will announce on Monday, February 20th, 2017 at the Acute Leukemia XVI symposium in Munich, Germany that it will be launching REMAIN™, an international…
Read More...

The US Food and Drug Administration has accepted for filing of Intellipharmaceutics International’s New Drug Application ("NDA") seeking authorization to market its Rexista…
Read More...

Momenta Pharmaceuticals has announced that Pfizer, Sandoz’s contracted Glatopa (glatiramer acetate injection) fill/finish manufacturing partner has received a warning letter from the…
Read More...

Global healthcare and life science company Arix Bioscience has raised £100m in its Initial Public Offering (IPO) on the main market of the London Stock Exchange. The Offer was…
Read More...

Otsuka Pharmaceutical Co., Ltd. and Lundbeck Canada announce that Health Canada issued a Notice of Compliance for REXULTI (brexpiprazole) for the treatment of schizophrenia in adults.…
Read More...

Dauntless Pharmaceuticals, Inc., a privately held biopharmaceutical company focused on the development of specialty therapeutics announced the initiation of a Phase 1 clinical study to…
Read More...

Imprimis Pharmaceuticals, Inc.an ophthalmology-focused pharmaceutical company announced that it has begun shipping its core sterile ophthalmic medications to select customers from its…
Read More...

Takeda Pharmaceutical has completed its acquisition of Ariad Pharmaceuticals for $24.00 per share in cash. Takeda president and CEO Christophe Weber said: “We are very pleased to…
Read More...

Solasia Pharma K.K. and Lee’s Pharmaceutical Holdings Limited jointly announced that Solasia and Lee’s Pharma have entered into an exclusive agreement for the commercialization and…
Read More...

Mayne Pharma Group Limited announced the launch of butalbital acetaminophen (APAP) tablets 50 mg/300 mg in the United States. Butalbital / APAP is indicated for the treatment of tension…
Read More...

X-Chem, Inc. announced that it has expanded its collaboration with Janssen Biotech, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson, to discover new drug…
Read More...

Catalent  announced that it has completed the acquisition of Accucaps Industries Limited (Accucaps), the Canada-based developer and manufacturer of Over-the-Counter (OTC), high-potency…
Read More...

Vyome Biosciences, a clinical-stage specialty pharmaceutical company developing novel medicines for treating skin diseases caused by resistant microbes, announced top-line data from its…
Read More...

Amgen announced that the U.S. Food and Drug Administration (FDA) has approved Parsabiv™ (etelcalcetide) for the treatment of secondary hyperparathyroidism (HPT) in adult patients with…
Read More...

AMRI, a global contract research and manufacturing organization working to improve patient outcomes and quality of life, has entered an alliance with Bruker Daltonics and HighRes…
Read More...

GW Pharmaceuticals has unveiled positive top-line results from an exploratory Phase 2 placebo-controlled clinical study of a combination of tetrahydrocannabinol (THC) and cannabidiol…
Read More...

Jazz Pharmaceuticals plc \announced that the first patient has been enrolled in a Phase 2 clinical study evaluating JZP-110, a selective dopamine and norepinephrine reuptake inhibitor,…
Read More...

Quotient Clinical announces that it has acquired SeaView Research, expanding its operations into the USA. The acquisition combines Quotient and SeaView’s complementary customer…
Read More...

Aura Biosciences, a biotechnology company developing a new class of therapies to target and selectively destroy cancer cells using viral nanoparticle conjugates, announced that the U.S.…
Read More...